Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Cabozantinib's trials
Long-Term Extension Study for Participants Previously Enrolled in an Exelixis-Sponsored Study
Cabozantinib
Ongoing
Enrolling by invitation
Phase 3
Open NCT07620574 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record